Dominant epitope p21-40 of snRNP D protein recognized by both autoreactive T and B cells in lupus-prone MRL lpr/lpr mice

被引:0
|
作者
Ding, Chuanlin [1 ]
Cai, Yihua [1 ]
Yan, Jun [1 ]
机构
[1] Univ Louisville, Louisville, KY 40292 USA
来源
JOURNAL OF IMMUNOLOGY | 2010年 / 184卷
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
135.22
引用
收藏
页数:1
相关论文
共 50 条
  • [31] Therapeutic effects of artesunate on lupus-prone MRL/lpr mice are dependent on T follicular helper cell differentiation and activation of JAK2-STAT3 signaling pathway
    Dang, Wen-Zhen
    Li, Hui
    Jiang, Bing
    Nandakumar, Kutty Selva
    Liu, Kai-Fei
    Liu, Li-Xin
    Yu, Xiao-Chen
    Tan, Hui-Jing
    Zhou, Chun
    PHYTOMEDICINE, 2019, 62
  • [32] INCORPORATION, DISTRIBUTION, AND TURNOVER OF ARACHIDONIC-ACID WITHIN MEMBRANE PHOSPHOLIPIDS OF B220+ T-CELLS FROM AUTOIMMUNE-PRONE MRL-LPR/LPR MICE
    TOMITAYAMAGUCHI, M
    BABICH, JF
    BAKER, RC
    SANTORO, TJ
    JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 171 (03): : 787 - 800
  • [33] Dihydroartemisinin inhibits activation of the Toll-like receptor 4 signaling pathway and production of type I interferon in spleen cells from lupus-prone MRL/lpr mice
    Huang, Xueqin
    Xie, Zhijun
    Liu, Fenfen
    Han, Chunwen
    Zhang, Dongyu
    Wang, Dawei
    Bao, Xi
    Sun, Jing
    Wen, Chengping
    Fan, Yongsheng
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2014, 22 (01) : 266 - 272
  • [34] Effect of Human Mesenchymal Stem Cells on Xenogeneic T and B Cells Isolated from Lupus-Prone MRL.Faslpr Mice
    Lee, Hong Kyung
    Kim, Eun Young
    Kim, Hyung Sook
    Park, Eun Jae
    Lee, Hye Jin
    Lee, Tae Yong
    Kim, Kyung Suk
    Bae, Sang-Cheol
    Hong, Jin Tae
    Kim, Youngsoo
    Han, Sang-Bae
    STEM CELLS INTERNATIONAL, 2020, 2020
  • [35] IFN-γ- receptor is required for intrafollicular localization of autoreactive marginal zone-B cells in the spleens of lupus-prone MRL plus / plus mice
    Machida, T.
    Omori, T.
    Sakamoto, N.
    Zhang, X.
    Gilkeson, G.
    Sekine, H.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2016, 46 : 935 - 936
  • [36] Selective Targeting of B Cells with Agonistic Anti-CD40 Is an Efficacious Strategy for the Generation of Induced Regulatory T2-Like B Cells and for the Suppression of Lupus in MRL/lpr Mice
    Blair, Paul A.
    Chavez-Rueda, Karina A.
    Evans, Jamie G.
    Shlomchik, Mark J.
    Eddaoudi, Ayad
    Isenberg, David A.
    Ehrenstein, Michael R.
    Mauri, Claudia
    JOURNAL OF IMMUNOLOGY, 2009, 182 (06): : 3492 - 3502
  • [37] Therapeutic effects of the artemisinin analog SM934 on lupus-prone MRL/lpr mice via inhibition of TLR-triggered B-cell activation and plasma cell formation
    Yanwei Wu
    Shijun He
    Bingxin Bai
    Luyao Zhang
    Lu Xue
    Zemin Lin
    Xiaoqian Yang
    Fenghua Zhu
    Peilan He
    Wei Tang
    Jianping Zuo
    Cellular & Molecular Immunology, 2016, 13 : 379 - 390
  • [38] Therapeutic effects of the artemisinin analog SM934 on lupus-prone MRL/lpr mice via inhibition of TLR-triggered B-cell activation and plasma cell formation
    Wu, Yanwei
    He, Shijun
    Bai, Bingxin
    Zhang, Luyao
    Xue, Lu
    Lin, Zemin
    Yang, Xiaoqian
    Zhu, Fenghua
    He, Peilan
    Tang, Wei
    Zuo, Jianping
    CELLULAR & MOLECULAR IMMUNOLOGY, 2016, 13 (03) : 379 - 390
  • [39] EARLY INDUCTION OF ANTI-DOUBLE-STRANDED DNA ANTIBODIES IN LUPUS-PRONE MRL MICE INOCULATED WITH LY-24+ CELLS CLONED FROM LYMPH-NODE CELLS OF AN MRL/MP-LPR/LPR MOUSE - POSSIBLE EFFECT OF PUTATIVE CYTOKINES PRODUCED BY CLONED LY-24+ CELLS
    KANAI, Y
    ISONISHI, S
    KATAGIRI, T
    KOIZUMI, T
    MIURA, K
    KUROSAWA, Y
    IMMUNOLOGY LETTERS, 1990, 24 (01) : 49 - 55
  • [40] ACTIVATION OF B CELLS AND IMPAIR BALANCE BETWEEN T FOLLICULAR CELLS AND REGULATORY T CELLS INVOLVED IN HIGH FAT-DIET ASSOCIATED LUPUS DEVELOPMENT IN MRL/LPR MICE
    Patel, R.
    Meng, J.
    Ray, A.
    Shi, X.
    Posas-Mendoza, T.
    Hille, C. A.
    Hellmers, L.
    Quinet, R.
    Davis, W.
    Zakem, J.
    Keshavamurthy, C.
    You, Z.
    Zhang, X.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2022, 70 (02) : 656 - 656